Both human and mouse studies also demonstrated that gut bacterial composition can impact response to chemotherapy and immune checkpoint inhibitors; in melanoma, commensal bacteria enhanced the anti-tumor efficacy of PD-L1 checkpoint blockade [4]. The gene discussed is CD274; the disease is neoplasm.